Navigation Links
ThirdBiotech Announces Kemeta as Newest Sponsor
Date:8/8/2008

PHOENIX, Aug. 8 /PRNewswire/ -- ThirdBiotech Inc., (http://www.thirdbiotech.com), a biotechnology incubator and life sciences association, today announced that Kemeta, a medical device company specializing in the development and manufacture of breath acetone sensing technology and products, has become ThirdBiotech's newest sponsor.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070911/LATU119LOGO)

"We've successfully established ThirdBiotech as an organization for bringing together the life sciences industry. Now with the establishment of ThirdBiotech Research Group Incubator and Molecular Engineering Research Institute (MERI), we have a core competency center to support and facilitate transformation of researchers and technology into biotech and biodevice companies," said Jeff Morhet, Founder of ThirdBiotech. "We are pleased to have Kemeta join our growing group of sponsors including Arizona Cure, BIO5/University of Arizona, Business Auxiliary Service Corp, Canadian Arizona Business Council, Galbut & Galbut, GE Healthcare, Greater Phoenix Economic Council, InNexus Biotechnology and Osborn Maledon."

The next ThirdBiotech event will be held at 6PM on Thursday, August 21st at La Bocca Pizzeria & Wine Bar located at 7th and Mill Avenue in downtown Tempe, Arizona.

About Kemeta

Kemeta has developed a unique, compact breath analyzer to provide individuals on a weight loss regimen rapid and accurate feedback regarding their fat metabolism using breath acetone as the body's biomarker. The company name, Kemeta, is derived from ketone and metabolism.

Kemeta is a privately held, limited liability company headquartered in Mesa, Arizona. Kemeta has a fully equipped, state-of-the-art R&D laboratory to develop, commercialize and expand Kemeta's products and technology. For more information about
'/>"/>

SOURCE ThirdBiotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. ThirdBiotech Launches Research Institute to Promote Formation and Growth of Arizona-Based Biotech Companies
2. ThirdBiotech Networking Group Launches
3. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
4. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
5. Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008
6. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
7. Anesiva Announces Second Quarter 2008 Financial Results and Update
8. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
9. Odyssey Thera Announces Milestone Achievement in Pfizer Alliance
10. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
11. Ondine Announces Publication of Positive Results from Pseudomonas aeruginosa Eradication Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... The next implants made from the PEEK-OPTIMA® ... (European) approval. The CE mark is necessary for distributing ... the European Union. Following the Class IIb approval route, ... supplied by the Turkey-based company Osimplant for the treatment ... Expandable Bladed HA PEEK Cage line of spinal implants, ...
(Date:3/4/2015)...  Brooklyn residents now have a new place to ... injuries. Nunzio Saulle , M.D., a board-certified physiatrist, ... NJS Physical Medicine and Rehabilitation (PM&R) practice in ... 2015. Health Plus Management, LLC is managing the day-to-day ... Flatbush Avenue. This new PM&R practice will treat patients ...
(Date:3/4/2015)... PRC Clinical, a full-service, Contract ... Area, will exhibit and present at the Outsourcing ... March 25th and 26th in Tel Aviv, Israel. ... life science companies seeking to conduct U.S. Food and ... all phases of human trials, from Phase I studies ...
(Date:3/4/2015)... California (PRWEB) March 04, 2015 ... (PCR) represents one of the fastest growing technologies in ... biologists in subcellular visualization is driving growth in nucleic ... for deeper understanding of gene expressions will continue to ... Expanding applications in fields ranging from pharma, biotech, food ...
Breaking Biology Technology:Invibio’s PEEK-OPTIMA® HA Enhanced Gains Momentum: New Implant Receives European Approval 2Invibio’s PEEK-OPTIMA® HA Enhanced Gains Momentum: New Implant Receives European Approval 3NJS Physical Medicine & Rehabilitation Opening on Flatbush Avenue, Brooklyn, NY 2PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 2PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 3PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 4Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 2Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 3Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 4
... Like most states, Wisconsin has long offered specialized ... it has lacked credit programs aimed at leveraging seed ... to change. Act 255, a tax-credit package that passed ... through an administrative rule process this summer, will provide ...
... Fiserv Imagesoft , a unit of Fiserv, ... services offering for its clients that have licensed ... ,The new multiple-option service is designed to ensure ... quickly, without interruption, after virtually any hardware, software ...
... of E. coli. Source: NAIAD Biodefense . ... on disease-causing pathogens, including ones that could be used ... will team with an information technology company, SRA ... library of data on these infectious agents and their ...
Cached Biology Technology:State investment incentives aimed at luring angels to start-up companies 2UW-Madison joins effort to build public pathogen bioinformatics database 2
(Date:2/24/2015)... Feb. 24, 2015 Research and Markets ... of the "Global 2D Gesture Recognition Market ... The analysts forecast the Global 2D Gesture ... 32.12% over the period 2014-2019 The ... sectors is one of the major trends in ...
(Date:2/13/2015)... , Feb. 13, 2015 ACT ... company that aims to transform cancer genomic information ... that the company has raised US$ 8 million in ... Based in Taipei, Taiwan , ... ACTDrug™, ACTOnco™. With the aim to implement next ...
(Date:2/10/2015)... 2015  Alere Inc. (NYSE: ALR), a global ... for the quarter ended December 31, 2014. ... of Alere said, "We made substantial progress in ... global leader in rapid diagnostics and delivering against ... divestiture in early January enabled us to substantially ...
Breaking Biology News(10 mins):Global 2D Gesture Recognition Market 2015-2019 with Cognitec Systems, CogniVue, eyeSight Mobile Technologies & PointGrab Dominating 2ACT Genomics Raises $8 Million in its First Private Funding Round 2Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33Alere Inc. Announces Fourth Quarter 2014 Results 34
... - Technology has transformed the way humans interact with the ... that will drive growth in marine and maritime sectors into ... will gather at the 3rd Marine Board Forum in Brussels ... has convened this flagship event on the understanding that technology ...
... Lugano-CH/Aurora-US-CO/Geneva-CH, 18 April 2012 -- New techniques for identifying ... screening, a nanotech ,nose, and a method to examine ... according to presentations at the 3rd European Lung Cancer ... lung cancer is vital to improve lung cancer survival ...
... genetic signature identified by Spanish researchers may provide doctors ... early stage lung cancer are at low or high ... 3rd European Lung Cancer Conference in Geneva. Their work ... Non-small cell lung cancer is a disease that ...
Cached Biology News:New technologies for a blue future 2Early detection techniques offer hope for improved outcomes in lung cancer patients 2Early detection techniques offer hope for improved outcomes in lung cancer patients 3Early detection techniques offer hope for improved outcomes in lung cancer patients 4Gene signature helps identify risk of relapse in lung cancer patients 2
Rabbit polyclonal to Survivin DEx3 ( Abpromise for all tested applications). entrezGeneID: 332 SwissProtID: O15392...
Smac/DIABLO (mouse) (CT) rabbit polyclonal antibody...
ABCA1 Immunogen: Mouse ABCA1-expressing HeLa stable transfectants. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Anti-rat Dipeptidyl Peptidase IV (DPP IV), CD26, Clone 5E8, Monoclonal Antibody...
Biology Products: